Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
57
ASCU.TO Quote, Financials, Valuation and Earnings
Last price:
$5.79
Seasonality move
:
7.37%
Day range:
$5.63 - $5.91
52-week range:
$1.68 - $6.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.69x
Volume:
220.8K
Avg. volume:
537.7K
1-year change:
193.91%
Market cap:
$1B
Revenue:
--
EPS (TTM):
-$0.07
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $22.8K | $94K | $109.4K | $149.8K | $161.7K | |
| Gross Profit | -$22.8K | -$94K | -$109.4K | -$149.8K | -$161.7K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.7M | $3.8M | $2.4M | $2.1M | $2.5M | |
| Other Inc / (Exp) | -- | -$761.9K | -$19.5K | -$1.4M | $377.5K | |
| Operating Expenses | $3.7M | $10.5M | $9.1M | $8.5M | $7.3M | |
| Operating Income | -$3.7M | -$10.6M | -$9.2M | -$8.6M | -$7.5M | |
| Net Interest Expenses | $3.2M | $5M | $488.2K | $21.6K | $1.7M | |
| EBT. Incl. Unusual Items | -$6.8M | -$16.4M | -$9.3M | -$9.4M | -$10.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$6.8M | -$16.4M | -$9.3M | -$9.4M | -$10.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.8M | -$16.4M | -$9.3M | -$9.4M | -$10.2M | |
| Basic EPS (Cont. Ops) | -$0.25 | -$0.35 | -$0.11 | -$0.09 | -$0.09 | |
| Diluted EPS (Cont. Ops) | -$0.25 | -$0.35 | -$0.11 | -$0.09 | -$0.09 | |
| Weighted Average Basic Share | $27M | $47M | $82.3M | $105.5M | $115.1M | |
| Weighted Average Diluted Share | $27M | $47M | $82.3M | $105.5M | $115.1M | |
| EBITDA | -$3.7M | -$10.5M | -$9.1M | -$8.5M | -$7.3M | |
| EBIT | -$3.7M | -$10.6M | -$9.2M | -$8.6M | -$7.5M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$3.7M | -$10.6M | -$9.2M | -$8.6M | -$7.5M | |
| Operating Income (Adjusted) | -$3.7M | -$10.6M | -$9.2M | -$8.6M | -$7.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $22.7K | $30K | $36.2K | $43.6K | -$20.7K | |
| Gross Profit | -$22.7K | -$30K | -$36.2K | -$43.6K | $20.7K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.5M | $197.2K | $347.4K | $743.4K | $909K | |
| Other Inc / (Exp) | $1.3K | -$43K | -$63.1K | -$200.6K | -- | |
| Operating Expenses | $2.5M | $1.5M | $1.4M | $2M | $1.9M | |
| Operating Income | -$2.6M | -$1.5M | -$1.5M | -$2.1M | -$1.9M | |
| Net Interest Expenses | $1.2M | $211.6K | $17.4K | $390.1K | $1.4M | |
| EBT. Incl. Unusual Items | -$3.7M | -$1.6M | -$1.9M | -$2.5M | -$3.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$3.9M | -$1.8M | -$1.9M | -$2.5M | -$3.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.7M | -$1.6M | -$1.9M | -$2.5M | -$3.4M | |
| Basic EPS (Cont. Ops) | -$0.08 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | |
| Diluted EPS (Cont. Ops) | -$0.08 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | |
| Weighted Average Basic Share | $49.1M | $88.7M | $109M | $109.5M | $178.3M | |
| Weighted Average Diluted Share | $49.1M | $88.7M | $109M | $109.5M | $178.3M | |
| EBITDA | -$2.5M | -$1.5M | -$1.4M | -$2M | -$1.9M | |
| EBIT | -$2.6M | -$1.5M | -$1.5M | -$2.1M | -$1.9M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$2.6M | -$1.5M | -$1.5M | -$2.1M | -$1.9M | |
| Operating Income (Adjusted) | -$2.6M | -$1.5M | -$1.5M | -$2.1M | -$1.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $77.9K | $112.5K | $134.9K | $160.6K | $85.2K | |
| Gross Profit | -$67.5K | -$112.5K | -$134.9K | -$160.6K | -$85.2K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.2M | $4.1M | $1.8M | $2.6M | $2.4M | |
| Other Inc / (Exp) | -$294.9K | -$530.3K | -$1.6M | $466K | -- | |
| Operating Expenses | $9.5M | $9.5M | $6.9M | $8.7M | $7.7M | |
| Operating Income | -$9.6M | -$9.6M | -$7M | -$8.9M | -$7.8M | |
| Net Interest Expenses | $3.1M | $2.4M | $214.9K | $1.5M | $2.2M | |
| EBT. Incl. Unusual Items | -$11.7M | -$12.3M | -$7.7M | -$9.5M | -$10.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$12.5M | -$8M | -$9.6M | -$10.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$14.1M | -$12.3M | -$7.7M | -$9.5M | -$10.1M | |
| Basic EPS (Cont. Ops) | -$0.27 | -$0.17 | -$0.08 | -$0.09 | -$0.07 | |
| Diluted EPS (Cont. Ops) | -$0.37 | -$0.17 | -$0.08 | -$0.09 | -$0.07 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$9.8M | -$9.5M | -$6.9M | -$8.7M | -$7.7M | |
| EBIT | -$8.3M | -$9.6M | -$7M | -$8.9M | -$7.8M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$9.6M | -$9.6M | -$7M | -$8.9M | -$7.8M | |
| Operating Income (Adjusted) | -$8.3M | -$9.6M | -$7M | -$8.9M | -$7.8M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $85.9K | $111.8K | $122.4K | $46K | -- | |
| Gross Profit | -$85.9K | -$111.8K | -$122.4K | -$46K | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.8M | $1.3M | $1.8M | $2.4M | -- | |
| Other Inc / (Exp) | -$59.1K | -$1.7M | $133.9K | -$758.2K | -- | |
| Operating Expenses | $7.2M | $5.1M | $5.3M | $5.6M | -- | |
| Operating Income | -$7.3M | -$5.2M | -$5.4M | -$5.7M | -- | |
| Net Interest Expenses | $545K | $214.9K | $1.5M | $1.7M | -- | |
| EBT. Incl. Unusual Items | -$7.7M | -$6.2M | -$6.2M | -$6.1M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$7.8M | -$6.2M | -$6.2M | -$6.4M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.7M | -$6.2M | -$6.2M | -$6.1M | -- | |
| Basic EPS (Cont. Ops) | -$0.10 | -$0.06 | -$0.06 | -$0.04 | -- | |
| Diluted EPS (Cont. Ops) | -$0.10 | -$0.06 | -$0.06 | -$0.04 | -- | |
| Weighted Average Basic Share | $240.1M | $312.7M | $328.1M | $473.8M | -- | |
| Weighted Average Diluted Share | $240.1M | $312.7M | $328.1M | $473.8M | -- | |
| EBITDA | -$7.2M | -$5.1M | -$5.3M | -$5.6M | -- | |
| EBIT | -$7.3M | -$5.2M | -$5.4M | -$5.7M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$7.3M | -$5.2M | -$5.4M | -$5.7M | -- | |
| Operating Income (Adjusted) | -$7.3M | -$5.2M | -$5.4M | -$5.7M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.8M | $34.5M | $26.9M | $13.8M | $45.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $96.9K | $509.8K | $95K | $13.4M | $176.5K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $2.6M | $150.4K | $122.1K | $208.2K | $244K | |
| Total Current Assets | $11.9M | $35.1M | $27.1M | $27.3M | $46.1M | |
| Property Plant And Equipment | $11M | $2.7M | $3.8M | $4.8M | $6.2M | |
| Long-Term Investments | -- | -- | $222.2K | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $609.5K | $2.3M | $3.3M | $4.5M | $6M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $22.9M | $68.7M | $94.3M | $150.4M | $194.8M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $3M | $2.1M | $3.4M | $9.3M | $2.9M | |
| Current Portion Of Long-Term Debt | -- | $8.6M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $43.3K | $65.1K | $84.9K | $23K | |
| Other Current Liabilities | -- | -- | -- | -- | $8.6M | |
| Total Current Liabilities | $5.8M | $11.7M | $4.8M | $11.1M | $12.3M | |
| Long-Term Debt | $8.1M | $145.3K | $90.8K | $4K | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14M | $13.1M | $4.9M | $38.9M | $44.4M | |
| Common Stock | $14.8M | $74.1M | $116.5M | $146.6M | $197.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $8.9M | $55.7M | $89.4M | $111.5M | $150.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $8.9M | $55.7M | $89.4M | $111.5M | $150.4M | |
| Total Liabilities and Equity | $22.9M | $68.7M | $94.3M | $150.4M | $194.8M | |
| Cash and Short Terms | $11.8M | $34.5M | $26.9M | $13.8M | $45.6M | |
| Total Debt | $8.1M | $8.7M | $155.8K | $88.4K | $23K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.6M | $38.4M | $16.2M | $11.5M | $61.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $135.2K | $98.5K | $42.1K | $41.9K | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $114.8K | $251.6K | $444.3K | $464.7K | -- | |
| Total Current Assets | $5.9M | $38.8M | $16.7M | $12M | $62.8M | |
| Property Plant And Equipment | $32.5M | $3.8M | $4.8M | $5.8M | $142.8M | |
| Long-Term Investments | -- | $196.5K | $181.2K | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | $3.4M | $4.5M | $5.6M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $38.4M | $100.5M | $136.3M | $144.1M | $388.3M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | $5.9M | $752.8K | $613.3K | -- | |
| Current Portion Of Long-Term Debt | $16.6M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $14K | $53.3K | $87K | $39.2K | -- | |
| Other Current Liabilities | -- | -- | -- | $9.6M | -- | |
| Total Current Liabilities | $20.9M | $7.1M | $10.5M | $11.7M | $13.9M | |
| Long-Term Debt | -- | $109.9K | $21.6K | -- | $119.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $20.9M | $7.2M | $18M | $33.6M | $166.3M | |
| Common Stock | $30.4M | $118.1M | $150.4M | $150.7M | $272.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $17.4M | $93.2M | $118.4M | $110.5M | $222M | |
| Total Liabilities and Equity | $38.4M | $100.5M | $136.3M | $144.1M | $388.3M | |
| Cash and Short Terms | $5.6M | $38.4M | $16.2M | $11.5M | $61.7M | |
| Total Debt | $10.1M | $163.5K | $108.1K | $39.2K | $128.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.8M | -$16.4M | -$9.3M | -$9.4M | -$10.2M | |
| Depreciation & Amoritzation | $22.8K | $94K | $108.1K | $149.8K | $161.7K | |
| Stock-Based Compensation | $584.8K | $3.7M | $2.4M | $3.1M | $1.9M | |
| Change in Accounts Receivable | -$51K | -$406.2K | $216.1K | $220K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2.1M | -$9.2M | -$4.6M | -$15.6M | -$13.3M | |
| Capital Expenditures | $17.9M | $23.3M | $38.8M | $36.8M | $30M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$11.1M | -$23.3M | -$38.8M | -$36.8M | -$30M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.7M | $7.5M | -- | -- | -- | |
| Long-Term Debt Repaid | -$3.8M | -$172.9K | -$62.4K | -$86.4K | -$87.5K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $17.9M | $2.2M | -- | $6.6M | $38.3M | |
| Cash From Financing | $22.9M | $57.7M | $34M | $39.9M | $74M | |
| Beginning Cash (CF) | $11.8M | $34.5M | $26.9M | $13.8M | $45.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.7M | $25.1M | -$9.7M | -$12.6M | $29.1M | |
| Ending Cash (CF) | $21.5M | $59.6M | $17M | $1.1M | $73.1M | |
| Levered Free Cash Flow | -$20M | -$32.5M | -$43.4M | -$52.4M | -$43.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.9M | -$1.8M | -$1.9M | -$2.5M | -$3.8M | |
| Depreciation & Amoritzation | $23.8K | $31.3K | $36.1K | $43.4K | -$52.7K | |
| Stock-Based Compensation | $1.1M | $331.7K | $514.9K | $967.6K | $386.1K | |
| Change in Accounts Receivable | $19.9K | -$27.8K | $84.5K | -$200 | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$1.6M | $3.3M | -$11M | -$1.1M | -$144.7K | |
| Capital Expenditures | $13.6M | $8.9M | $4.5M | $6M | $33.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$13.3M | -$8.9M | -$4.5M | -$6M | -$29.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $7.6M | -$116K | -- | -- | -- | |
| Long-Term Debt Repaid | -$18.6K | -$21.8K | -$21.4K | -$21.7K | -- | |
| Repurchase of Common Stock | -- | -- | -- | $44.8K | -- | |
| Other Financing Activities | $92.6K | -- | -- | $3.7M | -- | |
| Cash From Financing | $14.8M | $633.6K | -$67.5K | $3.7M | $9.8M | |
| Beginning Cash (CF) | $5.6M | $38.4M | $16.2M | $11.5M | $61.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -$269.4K | |
| Additions / Reductions | -$103.9K | -$5M | -$15.6M | -$3.5M | -$19.9M | |
| Ending Cash (CF) | $5.5M | $33.4M | $615.7K | $8M | $41.6M | |
| Levered Free Cash Flow | -$15.2M | -$5.6M | -$15.5M | -$7.1M | -$33.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$12.5M | -$8M | -$9.6M | -$10.6M | |
| Depreciation & Amoritzation | -- | $114K | $136.5K | $162.6K | $56K | |
| Stock-Based Compensation | $3.1M | $2.6M | $3M | $3M | $1.5M | |
| Change in Accounts Receivable | -- | -$129K | $76.3K | $196.3K | -$66.8K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$3.3M | -$17.3M | -$14.6M | -$4M | |
| Capital Expenditures | $13.6M | $36.9M | $38.6M | $27.6M | $74.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$36.9M | -$38.6M | -$27.6M | -$70.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$80.7K | -$64.2K | -$87.5K | -- | |
| Repurchase of Common Stock | -- | -- | -- | $103.7K | -$103.7K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $69.9M | $34.7M | $37.3M | $125.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $29.7M | -$21.5M | -$5M | $49.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -$40.2M | -$56M | -$42.2M | -$78.8M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.8M | -$6.2M | -$6.2M | -$6.4M | -- | |
| Depreciation & Amoritzation | $87.5K | $111.4K | $122.7K | $13.8K | -- | |
| Stock-Based Compensation | $2.1M | $2.6M | $2.5M | $2M | -- | |
| Change in Accounts Receivable | $241.7K | $92.5K | $66.9K | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$321.3K | -$12.8M | -$11.8M | -$2.1M | -- | |
| Capital Expenditures | $32.9M | $31M | $21.4M | $65.7M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$32.9M | -$31M | -$21.4M | -$61.3M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$62.6K | -$64.4K | -$65.5K | -$44.3K | -- | |
| Repurchase of Common Stock | -- | -- | $103.6K | -- | -- | |
| Other Financing Activities | -- | -- | $30.6M | -- | -- | |
| Cash From Financing | $34M | $33.3M | $30.4M | $80M | -- | |
| Beginning Cash (CF) | $96.2M | $85M | $42.9M | $187.1M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | $769.9K | -- | |
| Additions / Reductions | $842.5K | -$10.5M | -$2.8M | $17.4M | -- | |
| Ending Cash (CF) | $97.1M | $74.4M | $40.1M | $205.2M | -- | |
| Levered Free Cash Flow | -$33.2M | -$43.9M | -$33.2M | -$67.8M | -- | |
Get ASCU.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ASCU.TO
Sector
P/E ratio
--
19.88x
PEG ratio
--
-0.02x
P/B ratio
4.69x
1.85x
Price / LTM sales
--
1.65x
Growth Metrics
ASCU.TO
Sector
Revenue growth
--
2.4%
Earnings growth
16.16%
--
Revenue (5-year growth)
--
3.24%
Earnings forecast
--
$0.03
Profitability
ASCU.TO
Sector
Profitability FY 2024
-$161.7K
--
Return on invested capital
-5.01%
-9.18%
Return on assets
-4.23%
-10.59%
Return on equity
-5.86%
-9.79%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
10
Estimated Next Earnings Date
May
12
Balance Sheet
ASCU.TO
Sector
Total cash
$61.7M
$2.6M
Short term investments
--
$217K
Total assets
$194.8M
$16.7M
Long term debt
$128.1M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
51
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
75
PRLB alert for Feb 9
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
